Mesoblast.

No events began in the chosen period. Widen it, or reset.

• FDA Structural
  FDA issued a warning letter to NeoGen regarding a product quality defect on October 7, 2026.
  Moves Mesoblast

  Thu 17:56
• United States Food and Drug Administration Structural
  Law references FDA approved ingredients for ban, involving Gavin Newsom.
  Moves Mesoblast

  Tue 04:19
• Nasdaq Structural
  Windward Bio successfully listed on the Nasdaq exchange and is a portfolio company of Qiming Venture Partners.
  Moves Mesoblast

  07:13
• Japan Shared context
  Japan and PLDT, Inc. were identified as communication services companies.
  Moves Mesoblast

  Thu 08:44
• Europe Shared context
  EU leaders met in Dublin for peace talks, with Meloni emphasizing Ukraine support and Kushner engaging Russia.
  Moves Mesoblast

  07:14
• Melbourne Shared context
  The Australian Services Union opposes council workers' wage increases and enforces austerity agenda.
  Moves Mesoblast

  Thu 08:33

• Silviu Itescu Structural

  Silviu Itescu serves as the founder and current Chief Executive Officer of Mesoblast.

  Well supportedNov 6
  Mesoblast → Silviu Itescu

  Silviu Itescu → Mesoblast
• FDA Structural

  Mesoblast's commercial viability and product availability are fundamentally dependent on regulatory approvals and oversight provided by the FDA.

  Well supportedNov 6
  Mesoblast → FDA

  FDA → Mesoblast
• Nasdaq Structural

  Mesoblast is a publicly traded company listed on the Nasdaq stock exchange.

  Some supportSep 13
  Mesoblast → Nasdaq

  Nasdaq → Mesoblast
• United States Food and Drug Administration Structural

  The US FDA formally granted RMAT designation to Mesoblast, establishing a regulatory oversight relationship.

  Some supportJul 14
  Mesoblast → United States Food and Drug Administration

  United States Food and Drug Administration → Mesoblast
• Australian Securities Exchange Structural

  Mesoblast is a publicly traded company listed on the Australian Securities Exchange.

  Some supportOct 29
  Mesoblast → Australian Securities Exchange

  Australian Securities Exchange → Mesoblast
• William Burns Structural

  William Burns holds a formal governance role as a director of Mesoblast.

  Some supportNov 6
  Mesoblast → William Burns

  William Burns → Mesoblast
• State Street Corporation Transactional

  State Street Corporation accumulated a 5.1% equity stake in Mesoblast as part of a specific investment transaction.

  Some supportAug 17
  Mesoblast → State Street Corporation

  State Street Corporation → Mesoblast
• Japan Shared context

  Mesoblast is seeking conditional regulatory approval for its lead product within Japan.

  Some supportJul 18
  Mesoblast → Japan

  Japan → Mesoblast